PRMT5 and neoplasm: Furthermore, PRMT5 inhibitors are particularly effective in MTAP-deleted intrahepatic cholangiocarcinoma, where they enhance the efficacy of cisplatin and gemcitabine and suppress the growth of tumor organoids [591].